Chairman Dinesh Khara however reiterated the bank’s target of maintaining a return on equity (RoE) of 15% on a sustainable basis even as he maintained that the bank will continue to record loan growth of 14% to 16%.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the